Zacks Small Cap Analysis – TELO Declares Promising Getting older Reversal Check Outcomes – Model Slux
By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescription drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm creating a product designed to elongate the DNA’s protecting telomere caps. Beforehand reported preclinical assessments have proven proof that Telomir-1, the corporate’s major remedy, can lengthen telomeres and preliminary animal testing illustrates the potential … Read more
